$233.49
00.00%
Pre-Market: Sep 20, 4:39 PM EDT
15 minutes delayed
Madrigal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Madrigal Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $-7.10 | $-7.54 | 5.84 % |
Mar 2024 | 2024-05-07 | $-7.38 | $-6.28 | -17.5 % |
Dec 2023 | 2024-02-28 | $-5.68 | $-5.28 | -7.58 % |
Sep 2023 | 2023-11-06 | $-5.34 | $-4.92 | -8.54 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-07 | $14.64M | $4.02M | 264.1 % |
Madrigal Pharmaceuticals (MDGL) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 7, 2024 for Q2.
The Actual EPS was $-7.10, which beat the estimate of $-7.54.
The Actual Revenue was $14.6M, which beat the estimate of $4M.
Browse earnings estimates, EPS, and revenue on all stocks.